Hello. Sign in to personalize your visit. New user? Register now.  
Journal of Neurotrauma
A Preliminary Study of Intravenous Surfactants in Paraplegic Dogs: Polymer Therapy in Canine Clinical SCI

To cite this article:
Peter H. Laverty, Alenka Leskovar, Gert J. Breur, Joan R. Coates, Robert L. Bergman, William R. Widmer, James P. Toombs, Scott Shapiro, Richard B. Borgens. Journal of Neurotrauma. December 2004, 21(12): 1767-1777. doi:10.1089/neu.2004.21.1767.

Full Text: • PDF for printing (203.7 KB) • PDF w/ links (257.1 KB)


Peter H. Laverty
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana.
Alenka Leskovar
Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Veterinary Teaching Hospital, College Station, Texas.
Gert J. Breur
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana.
Joan R. Coates
Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Veterinary Teaching Hospital, College Station, Texas.
Robert L. Bergman
Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Veterinary Teaching Hospital, College Station, Texas.
William R. Widmer
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana.
James P. Toombs
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana.
Scott Shapiro
Department of Neurosurgery, Indiana University Medical Center, Indianapolis, Indiana.
Richard B. Borgens, Ph.D.
Department of Basic Medical Sciences, Center for Paralysis Research, Purdue University, West Lafayette, Indiana.
Department of Biomedical Engineering, College of Engineering, Purdue University, West Lafayette, Indiana.

Hydrophilic polymers, both surfactants and triblock polymers, are known to seal defects in cell membranes. In previous experiments using laboratory animals, we have exploited this capability using polyethylene glycol (PEG) to repair spinal axons after severe, standardized spinal cord injury (SCI) in guinea pigs. Similar studies were conducted using a related co-polymer Poloxamer 188 (P 188). Here we carried out initial investigations of an intravenous application of PEG or P 188 (3500 Daltons, 30% w/w in saline; 2 mL/kg I.V. and 2 mL/kg body weight or 300 mL P 188 per kg, respectively) to neurologically complete cases of paraplegia in dogs. Our aim was to first determine if this is a clinically safe procedure in cases of severe naturally occurring SCI in dogs. Secondarily, we wanted to obtain preliminary evidence if this therapy could be of clinical benefit when compared to a larger number of similar, but historical, control cases. Strict entry criteria permitted recruitment of only neurologically complete paraplegic dogs into this study. Animals were treated by a combination of conventional and experimental techniques within 72 h of admission for spinal trauma secondary to acute, explosive disk herniation. Outcome measures consisted of measurements of voluntary ambulation, deep and superficial pain perception, conscious proprioception in hindlimbs, and evoked potentials (somatosensory evoked potentials [SSEP]). We determined that polymer injection is a safe adjunct to the conventional management of severe neurological injury in dogs. We did not observe any unacceptable clinical response to polymer injection; there were no deaths, nor any other problem arising from, or associated with, the procedures. Outcome measures over the 6–8-week trial were improved by polymer injection when compared to historical cases. This recovery was unexpectedly rapid compared to these comparator groups. The results of this pilot trial provides evidence consistent with the notion that the injection of inorganic polymers in acute neurotrauma may be a simple and useful intervention during the acute phase of the injury.

Free first page

This paper was cited by:

INTRAVENOUS POLYETHYLENE GLYCOL SUCCESSFULLY TREATS SEVERE ACCELERATION-INDUCED BRAIN INJURY IN RATS AS ASSESSED BY MAGNETIC RESONANCE IMAGING
Philip Smucker, S. K. Hekmatyar, Navin Bansal, Richard B. Rodgers, Scott A. Shapiro, Richard B. Borgens
Neurosurgery. Jun 2009, Vol. 64, No. 5: 984-990
CrossRef
Neural Precursors from Canine Skin: A New Direction for Testing Autologous Cell Replacement in the Brain
Michael J. Valenzuela, Sophia K. Dean, Perminder Sachdev, Bernard E. Tuch, Kuldip S. Sidhu
Stem Cells and Development. Dec 2008, Vol. 17, No. 6: 1087-1094
Abstract | Full Text PDF | Reprints & Permissions
Repairing the Damaged Spinal Cord and Brain with Nanomedicine
Youngnam Cho, Riyi Shi, Richard Borgens, Albena Ivanisevic
Small. Nov 2008, Vol. 4, No. 10: 1676-1681
CrossRef
Neural tissue engineering of the CNS using hydrogels
David R. Nisbet, Kylie E. Crompton, Malcolm K. Horne, David I. Finkelstein, John S. Forsythe
Journal of Biomedical Materials Research Part B: Applied Biomaterials. Nov 2008, Vol. 87B, No. 1: 251-263
CrossRef
Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death
Youngnam Cho, Riyi Shi, Richard B Borgens, Albena Ivanisevic
Nanomedicine. Sep 2008, Vol. 3, No. 4: 507-519
CrossRef
Emerging drugs for spinal cord injury
Darryl C Baptiste, Michael G Fehlings
Expert Opinion on Emerging Drugs. Apr 2008, Vol. 13, No. 1: 63-80
CrossRef
Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat
David S. Ditor, Sunil M. John, Josee Roy, Jeffrey C. Marx, Colin Kittmer, Lynne C. Weaver
Journal of Neuroscience Research. Jun 2007, Vol. 85, No. 7: 1458-1467
CrossRef
Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy
N D Jeffery, P M Smith, A Lakatos, C Ibanez, D Ito, R J M Franklin
Spinal Cord. Nov 2006, Vol. 44, No. 10: 584-593
CrossRef
Polyethylene glycol treatment after traumatic brain injury reduces β-amyloid precursor protein accumulation in degenerating axons
Andrew O. Koob, Richard B. Borgens
Journal of Neuroscience Research. Jul 2006, Vol. 83, No. 8: 1558-1563
CrossRef
Bioengineered Strategies for Spinal Cord Repair
Hiroshi Nomura, Charles H. Tator, Molly S. Shoichet
Journal of Neurotrauma. Apr 2006, Vol. 23, No. 3-4: 496-507
Abstract | Full Text PDF | Reprints & Permissions
Cancer researchers usher in dog days of medicine
George S Mack
Nature Medicine. Nov 2005, Vol. 11, No. 10: 1018-1018
CrossRef
Intravenous Polyethylene Glycol Inhibits the Loss of Cerebral Cells after Brain Injury
Andrew O. Koob, Bradley S. Duerstock, Charles F. Babbs, Yinlong Sun, Richard B. Borgens
Journal of Neurotrauma. Oct 2005, Vol. 22, No. 10: 1092-1111
Abstract | Full Text PDF | Reprints & Permissions
All articles
Previous Next